GEN ranks not only the top 10 publicly traded developed of editing-based therapies, but the top five privately held companies ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

Nanoneedle tech could enable disease monitoring in real time, allowing clinicians to take multiple, repeatable tests from the ...

Chrysalis partners with life science clients, from early-stage biofirms to pharmaceutical firms, CROs, and other life science ...

Novel T cell measurement system by Novoviah Pharmaceuticals demonstrates clinical disease detection and monitoring of celiac disease.

Sarepta halts Elevidys shipments for non-ambulatory DMD patients after a second patient death in three months post gene ...

June 26, 2025, is the 25th anniversary of the White House announcement of the first sequencing of the human genome, and July 28, 2025, marks the 30th anniversary of the publication of the first ...

Koby Baranes, PhD, head of science at Clock Bio, cautions, “Aging is not yet fully understood and existing models often fail ...

While commercial uptake by patients still lags and a recent court decision rekindles a legal battle, clinical successes continue.

Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.

A dual transcription factor activation method enables rapid generation of vascular organoids, accelerating modeling and therapy development.

A new study reveals how exercise influences major cell types in Alzheimer's disease, and points to potential targets for future therapies.